Improving survival in decompensated cirrhosis
- PMID: 22811919
- PMCID: PMC3395145
- DOI: 10.1155/2012/318627
Improving survival in decompensated cirrhosis
Abstract
Mortality in cirrhosis is consequent of decompensation, only treatment being timely liver transplantation. Organ allocation is prioritized for the sickest patients based on Model for End Stage Liver Disease (MELD) score. In order to improve survival in patients with high MELD score it is imperative to preserve them in suitable condition till transplantation. Here we examine means to prolong life in high MELD score patients till a suitable liver is available. We specially emphasize protection of airways by avoidance of sedatives, avoidance of Bilevel Positive Airway Pressure, elective intubation in grade III or higher encephalopathy, maintaining a low threshold for intubation with lesser grades of encephalopathy when undergoing upper endoscopy or colonoscopy as pre transplant evaluation or transferring patient to a transplant center. Consider post-pyloric tube feeding in encephalopathy to maintain muscle mass and minimize risk of aspiration. In non intubated and well controlled encephalopathy, frequent physical mobility by active and passive exercises are recommended. When renal replacement therapy is needed, night-time Continuous Veno-Venous Hemodialysis may be useful in keeping the daytime free for mobility. Sparing and judicious use of steroids needs to be borne in mind in treatment of ARDS and acute hepatitis from alcohol or autoimmune process.
Figures
Similar articles
-
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.J Hepatol. 2021 Feb;74(2):274-282. doi: 10.1016/j.jhep.2020.09.029. Epub 2020 Oct 8. J Hepatol. 2021. PMID: 33038432 Clinical Trial.
-
Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.Liver Int. 2009 Mar;29(3):392-8. doi: 10.1111/j.1478-3231.2008.01887.x. Liver Int. 2009. PMID: 19267864
-
Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.J Clin Exp Hepatol. 2018 Mar;8(1):50-57. doi: 10.1016/j.jceh.2017.06.001. Epub 2017 Jun 15. J Clin Exp Hepatol. 2018. PMID: 29743797 Free PMC article.
-
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.Liver Transpl. 2011 Oct;17(10):1137-51. doi: 10.1002/lt.22363. Liver Transpl. 2011. PMID: 21695771 Review.
-
Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.Dig Dis Sci. 2011 Apr;56(4):977-87. doi: 10.1007/s10620-010-1390-3. Epub 2010 Sep 16. Dig Dis Sci. 2011. PMID: 20844956 Review.
Cited by
-
Introducing an optimal liver allocation system for liver cirrhosis patients.Hepat Mon. 2013 Aug 30;13(8):e10479. doi: 10.5812/hepatmon.10479. eCollection 2013. Hepat Mon. 2013. PMID: 24098306 Free PMC article.
-
Proteomic study of advanced cirrhosis based on HCV to reveal potential biomarkers.Gastroenterol Hepatol Bed Bench. 2020 Winter;13(Suppl1):S113-S121. Gastroenterol Hepatol Bed Bench. 2020. PMID: 33585012 Free PMC article.
-
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis.Front Pharmacol. 2022 Dec 21;13:1049094. doi: 10.3389/fphar.2022.1049094. eCollection 2022. Front Pharmacol. 2022. PMID: 36618937 Free PMC article.
-
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes.Front Med (Lausanne). 2023 Jan 4;9:962337. doi: 10.3389/fmed.2022.962337. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36687427 Free PMC article.
-
Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis.World J Gastroenterol. 2014 Jul 14;20(26):8660-6. doi: 10.3748/wjg.v20.i26.8660. World J Gastroenterol. 2014. PMID: 25024623 Free PMC article. Clinical Trial.
References
-
- Jain A, Maloo M, Karachristos A, MacDonald B, Daly E, Patel V. Keeping patients transplantable with end stage liver disease and high MELD scores until we find them an organ. Proceedings of the ILTS 18th Annual International Congress; 2012; San Francisco, Calif, USA.
-
- Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gillespie B, Held PH. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transplantation. 2003;9(1):12–18. - PubMed
-
- Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470. - PubMed
-
- OPTN: Organ Procurement and Transplantation Network, http://optn.transplant.hrsa.gov/data/, 2012.
-
- OPTN: Organ Procurement and Transplantation Network, http://optn.transplant.hrsa.gov/latestData/rptData.asp, 2012.
LinkOut - more resources
Full Text Sources